We are live on ! Find out more
BSX icon

Boston Scientific

1,512 hedge funds and large institutions have $120B invested in Boston Scientific in 2024 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 617 increasing their positions, 489 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 83

26% more repeat investments, than reductions

Existing positions increased: 617 | Existing positions reduced: 489

9% more capital invested

Capital invested by funds: $111B → $120B (+$9.45B)

8% more funds holding

Funds holding: 1,3951,512 (+117)

8% more funds holding in top 10

Funds holding in top 10: 3639 (+3)

1.08% more ownership

Funds ownership: 89.89%90.98% (+1.1%)

13% less call options, than puts

Call options by funds: $797M | Put options by funds: $912M

Holders
1,512
Holders Change
+117
Holders Change %
+8.39%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+8.33%
% of All Funds
0.51%
New
218
Increased
617
Reduced
489
Closed
83
Calls
$797M
Puts
$912M
Net Calls
-$115M
Net Calls Change
+$168M
Name Holding Trade Value Shares
Change
Change in
Stake
NP
851
Ninepoint Partners
Ontario, Canada
$786K
BIM
852
Baldwin Investment Management
Pennsylvania
$781K +$8.98K +102 +1%
SPA
853
Sherbrooke Park Advisers
New York
$778K +$474K +5,385 +162%
BFO
854
Boston Family Office
Massachusetts
$777K
EWS
855
Eagle Wealth Strategies
New Jersey
$776K +$2.73K +31 +0.4%
PPWP
856
Premier Path Wealth Partners
New Jersey
$776K +$528 +6 +0.1%
BBA
857
Baader Bank Aktiengesellschaft
Germany
$770K -$87.8K -997 -10%
CFO
858
Callan Family Office
Pennsylvania
$768K +$757K +8,598 New
SFPG
859
Stonebridge Financial Planning Group
Florida
$766K +$182K +2,068 +32%
WT
860
Washington Trust
Rhode Island
$765K -$12.3K -140 -2%
AIA
861
Armor Investment Advisors
North Carolina
$763K
CGL
862
Clarius Group LLC
Washington
$761K +$49.9K +567 +7%
HIM
863
Hillsdale Investment Management
Ontario, Canada
$759K +$748K +8,500 New
GS
864
GTS Securities
New York
$758K -$6.46M -73,354 -90%
LFAS
865
Level Four Advisory Services
Texas
$753K +$67K +761 +10%
FRM
866
Fox Run Management
Connecticut
$749K -$297K -3,373 -29%
UOC
867
UBS O'Connor
Illinois
$744K +$133K +1,507 +22%
WFC
868
Western Financial Corp
California
$741K +$730K +8,291 New
CAMG
869
CWA Asset Management Group
Florida
$740K +$29.6K +336 +4%
BTD
870
BankPlus Trust Department
Mississippi
$736K +$725K +8,238 New
CC
871
Centiva Capital
New York
$729K -$602K -6,843 -46%
PPWM
872
Paragon Private Wealth Management
Kentucky
$728K +$135K +1,529 +23%
BDL
873
Banque de Luxembourg
Luxembourg
$727K +$714K +8,106 New
AIM
874
Anchor Investment Management
South Carolina
$727K +$701K +7,962 +4,524%
PI
875
PFG Investments
New York
$725K +$11K +125 +2%

BSX Hedge Fund Activity: Q4 2024 in Review

1,512 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2024, worth a combined $120B — up 8.5% from $111B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new BSX positions and 83 closed out — a net gain of 135 holders — while 617 added to existing stakes and 489 trimmed.

The largest buyer was BlackRock, adding an estimated $909M. The largest seller was Massachusetts Financial Services, cutting an estimated $529M.

  • 1,512 institutional investors held Boston Scientific (BSX) as of Q4 2024, up from 1,395 in Q3 2024.
  • Funds reported $120B of Boston Scientific stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 218 funds opened new Boston Scientific positions in Q4 2024 and 83 closed out, a net change of +135 holders.
  • The largest Boston Scientific buyer in Q4 2024 was BlackRock, an estimated $909M added.
  • The largest Boston Scientific seller in Q4 2024 was Massachusetts Financial Services, an estimated $529M sold.

Based on aggregated 13F filings for Q4 2024.